![](/img/cover-not-exists.png)
257 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH ADVANCED PROSTATE CANCER. RESULTS FROM A PHASE II MULTI-CENTRE, OPEN-LABEL, PILOT STUDY INVESTIGATING AN INITIAL
C. Maclean, F. Larsen, J. Drewe, A. Ulys, D. KaniušasVolume:
6
Year:
2007
Language:
english
DOI:
10.1016/s1569-9056(07)60256-5
File:
PDF, 328 KB
english, 2007